These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 15509712)
1. P-glycoprotein substrate binding domains are located at the transmembrane domain/transmembrane domain interfaces: a combined photoaffinity labeling-protein homology modeling approach. Pleban K; Kopp S; Csaszar E; Peer M; Hrebicek T; Rizzi A; Ecker GF; Chiba P Mol Pharmacol; 2005 Feb; 67(2):365-74. PubMed ID: 15509712 [TBL] [Abstract][Full Text] [Related]
2. Identification of ligand-binding regions of P-glycoprotein by activated-pharmacophore photoaffinity labeling and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. Ecker GF; Csaszar E; Kopp S; Plagens B; Holzer W; Ernst W; Chiba P Mol Pharmacol; 2002 Mar; 61(3):637-48. PubMed ID: 11854445 [TBL] [Abstract][Full Text] [Related]
3. A three-dimensional model for the substrate binding domain of the multidrug ATP binding cassette transporter LmrA. Ecker GF; Pleban K; Kopp S; Csaszar E; Poelarends GJ; Putman M; Kaiser D; Konings WN; Chiba P Mol Pharmacol; 2004 Nov; 66(5):1169-79. PubMed ID: 15304548 [TBL] [Abstract][Full Text] [Related]
4. Targeting drug-efflux pumps -- a pharmacoinformatic approach. Pleban K; Kaiser D; Kopp S; Peer M; Chiba P; Ecker GF Acta Biochim Pol; 2005; 52(3):737-40. PubMed ID: 16082413 [TBL] [Abstract][Full Text] [Related]
5. Characterization of the dexniguldipine binding site in the multidrug resistance-related transport protein P-glycoprotein by photoaffinity labeling and mass spectrometry. Borchers C; Boer R; Klemm K; Figala V; Denzinger T; Ulrich WR; Haas S; Ise W; Gekeler V; Przybylski M Mol Pharmacol; 2002 Jun; 61(6):1366-76. PubMed ID: 12021398 [TBL] [Abstract][Full Text] [Related]
6. Role of transmembrane domain/transmembrane domain interfaces of P-glycoprotein (ABCB1) in solute transport. Convergent information from photoaffinity labeling, site directed mutagenesis and in silico importance prediction. Chiba P; Mihalek I; Ecker GF; Kopp S; Lichtarge O Curr Med Chem; 2006; 13(7):793-805. PubMed ID: 16611068 [TBL] [Abstract][Full Text] [Related]
7. Exhaustive sampling of docking poses reveals binding hypotheses for propafenone type inhibitors of P-glycoprotein. Klepsch F; Chiba P; Ecker GF PLoS Comput Biol; 2011 May; 7(5):e1002036. PubMed ID: 21589945 [TBL] [Abstract][Full Text] [Related]
8. Both ATP sites of human P-glycoprotein are essential but not symmetric. Hrycyna CA; Ramachandra M; Germann UA; Cheng PW; Pastan I; Gottesman MM Biochemistry; 1999 Oct; 38(42):13887-99. PubMed ID: 10529234 [TBL] [Abstract][Full Text] [Related]
9. Identification of the domains of photoincorporation of the 3'- and 7-benzophenone analogues of taxol in the carboxyl-terminal half of murine mdr1b P-glycoprotein. Wu Q; Bounaud PY; Kuduk SD; Yang CP; Ojima I; Horwitz SB; Orr GA Biochemistry; 1998 Aug; 37(32):11272-9. PubMed ID: 9698374 [TBL] [Abstract][Full Text] [Related]
10. Identification and localization of three photobinding sites of iodoarylazidoprazosin in hamster P-glycoprotein. Isenberg B; Thole H; Tümmler B; Demmer A Eur J Biochem; 2001 May; 268(9):2629-34. PubMed ID: 11322883 [TBL] [Abstract][Full Text] [Related]
11. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein. Hafkemeyer P; Dey S; Ambudkar SV; Hrycyna CA; Pastan I; Gottesman MM Biochemistry; 1998 Nov; 37(46):16400-9. PubMed ID: 9819232 [TBL] [Abstract][Full Text] [Related]
12. Photoaffinity labeling of P-glycoprotein. Peer M; Csaszar E; Vorlaufer E; Kopp S; Chiba P Mini Rev Med Chem; 2005 Feb; 5(2):165-72. PubMed ID: 15720286 [TBL] [Abstract][Full Text] [Related]
13. Major photoaffinity drug labeling sites for iodoaryl azidoprazosin in P-glycoprotein are within, or immediately C-terminal to, transmembrane domains 6 and 12. Greenberger LM J Biol Chem; 1993 May; 268(15):11417-25. PubMed ID: 8098711 [TBL] [Abstract][Full Text] [Related]
14. Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies. Mora Lagares L; Minovski N; Caballero Alfonso AY; Benfenati E; Wellens S; Culot M; Gosselet F; Novič M Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517082 [TBL] [Abstract][Full Text] [Related]
15. Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1. Zhang X; Collins KI; Greenberger LM J Biol Chem; 1995 Mar; 270(10):5441-8. PubMed ID: 7890659 [TBL] [Abstract][Full Text] [Related]
16. Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1). He SM; Li R; Kanwar JR; Zhou SF Curr Med Chem; 2011; 18(3):439-81. PubMed ID: 21143116 [TBL] [Abstract][Full Text] [Related]
17. Reversing the direction of drug transport mediated by the human multidrug transporter P-glycoprotein. Sajid A; Lusvarghi S; Murakami M; Chufan EE; Abel B; Gottesman MM; Durell SR; Ambudkar SV Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29609-29617. PubMed ID: 33168729 [TBL] [Abstract][Full Text] [Related]
18. Molecular dissection of dual pseudosymmetric solute translocation pathways in human P-glycoprotein. Parveen Z; Stockner T; Bentele C; Pferschy S; Kraupp M; Freissmuth M; Ecker GF; Chiba P Mol Pharmacol; 2011 Mar; 79(3):443-52. PubMed ID: 21177413 [TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans. Jin MS; Oldham ML; Zhang Q; Chen J Nature; 2012 Oct; 490(7421):566-9. PubMed ID: 23000902 [TBL] [Abstract][Full Text] [Related]
20. Insertion of an arginine residue into the transmembrane segments corrects protein misfolding. Loo TW; Bartlett MC; Clarke DM J Biol Chem; 2006 Oct; 281(40):29436-40. PubMed ID: 16926162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]